Review LIDR Use Cases and sign up to lead one of these - prioritize these use cases, so that we can finalize the requirements for the first phase of LIDR
Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host
Marti can share the LIDR categorical data to instance data mapping for each element - DATE?
Call Schedule
send OOO via chat or email
LIDR White Paper Review
Reviewing the comments on the LIDR White Paper = LIDR White Paper
Need to check reference style and pick one
Reviewed comments on introduction - Still need to check for best place to talk about CLSI AUTO-16/IHE LAW (question: has anyone implemented in the US in production?)
Review updated LIDR content creation diagram:
What kind f content would come from FDA?
CLIA setting, at home use etc
maybe additional elements from the package insert once test is approved and that information is public
Need to make sure the linkage for any feedback / additionally submitted content is properly linked to the correct LIDR entry
Hung found some LIVD entries has split rows - Russ is checking for the exact examples
Does distribution include naming convention?
different labs may create different names for the same test
would the unqiue LIDR row ID help with that?
don't want to get hung up on single id again - labs need to report based on the LIDR fingerprint (all the correctly coded data like LOINC, SCT, proper specimen infomration, unit sof measure, UDI
Note that this diagram does not include the details of distribution - we left this here to make clear that content doesn’t just go into LIDR, but also comes back out - but there is feedback ability - hence the double-arrows
What if a lab decides to report slightly different from how the maunufacturer prefers - example Flu A/B test or HIV 1/2 test - manufacturer has single nominal results vs lab sets these up as 2 individual tests with ordinal test - both are valid and the latter is often used to ensure that display for provider is not changed in a way that information could get lost
LIDR administrator can make those updates
Who is the LIDR administrator - needs to be impartial
Ideally SHIELD community administers LIDR
In Figure 7 there is “Labs' conformance to LIDR' - what happens if the update is not in LIDR?
no reason for not including, unless mapping is incorrect
How does feedback from the labs to vendor work?
Via LIDR and or direct
Diagram ready to beautify - Russ will ask Peyton and team to do
Roadmap for LIDR - how do we make LIDR a reality?
Riki just drafted - ideally should become an actual tool, but that will need funding and assurance of impartial administation
may not move forward on just goodwill
Xavier might be able to help with the FHIR pilot of LIVD
Other notes:
Hung was approached by Siemens after his article https://doi.org/10.3343/alm.2024.0323 which mentioned SHIELD LIDR - fingers corssed we can get them to join/support
Pam has worked with Siemens in the past on LOINC mapping and teaching about LIVD format in US
This is from Norway
ACTION ITEMS
All read the roadmap and the how to get invovled
Review on 11/04 then send to Steering Committee for review and vote 11/05 or the next
0 Comments